You are currently viewing a placeholder content from Vimeo. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

More Information
Unblock content Accept required service and unblock content

Exciting News from Tiefenbacher Group!

We are thrilled to announce the grand inauguration of our newly constructed development and production facilities in Hyderabad, India! This marks a significant milestone in our mission to develop and manufacture high-quality, affordable pharmaceuticals for patients worldwide.

Our new facilities

Our state-of-the-art complex spans 4,000 m², featuring cutting-edge laboratories and production facilities designed to meet the highest safety and GxP compliance standards. The new facilities provide product development labs, analytical labs, administrative offices, and an employee canteen. A key highlight is our new oncology drug production unit, enabling us to expand our specialty pharmaceuticals portfolio. With over 20 leading highly potent oncology drugs in our launch pipeline, this investment strengthens our role as an innovation leader in the industry. Additionally, we held a groundbreaking ceremony for the expansion of the Production Block 1 which is used for other pharmaceuticals indications.

Festive inauguration ceremony

This memorable event was graced by our esteemed managing directors, Tiefenbacher family shareholders, and advisory board members. To mark this special occasion, we hosted a festive inauguration ceremony at our Hyderabad site, bringing together our employees, leadership team, and distinguished guests. The celebration featured inspiring speeches by our leadership team, including Swapnil Singh, Sandip Tarate, Oliver Schrader & Dr. Kristian Ruepp. As well as honored dignitaries, recognition of our dedicated project team, a vibrant cultural show, a live band performance, and a delightful dinner.

Tiefenbacher Group’s commitment

This expansion and celebration underscore Tiefenbacher Group’s commitment to innovation and excellence as a fully integrated global pharmaceutical company. Our Hyderabad site continues to set industry benchmarks with its advanced technologies, stringent quality standards, and dedication to improving global healthcare. A big thank you to our incredible team and partners who made this possible!

TIEFENBACHER API + INGREDIENTS, a part of TIEFENBACHER GROUP, is a pharmaceutical full-service distributor for high-quality APIs and controlled substances with value-added services. We offer more than 600+ APIs (Human + Veterinary) in all fourteen ATC-Groups for safe, reliable pharmaceuticals.
For more information around our raw materials with best value seal (Better Access – Better Quality – Better Quality), please contact TIEFENBACHER API + INGREDIENTS: info-api@tiefenbacher.com or visit us on: www.tiefenbacher-api.com